CD276 and non-small cell lung carcinoma: Firstly, although we assessed EGFR/B7H3 co-expression in a large cohort encompassing both driver-negative and EGFR-TKI-resistant NSCLC, other genomic subgroups and Caucasian populations remained understudied.